Corpus overview


MeSH Disease

HGNC Genes

There are no HGNC terms in the subcorpus

SARS-CoV-2 proteins

There are no SARS-CoV-2 protein terms in the subcorpus


SARS-CoV-2 Proteins
    displaying 1 - 1 records in total 1
    records per page

    Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study

    Authors: Daniel Ayoubkhani; Kamlesh Khunti; Vahe Nafilyan; Thomas Maddox; Ben Humberstone; Ian Diamond; Amitava Banerjee

    doi:10.1101/2021.01.15.21249885 Date: 2021-01-15 Source: medRxiv

    ObjectivesThe epidemiology of post-COVID syndrome ( PCS MESHD) is currently undefined. We quantified rates of organ-specific impairment following recovery from COVID-19 MESHD hospitalisation compared with those in a matched control group, and how the rate ratio (RR) varies by age, sex, and ethnicity. DesignObservational, retrospective, matched cohort study. SettingNHS hospitals in England. Participants47,780 individuals (mean age 65 years, 55% male) in hospital with COVID-19 MESHD and discharged alive by 31 August 2020, matched to controls on demographic and clinical characteristics. Outcome measuresRates of hospital readmission, all-cause mortality, and diagnoses of respiratory, cardiovascular, metabolic, kidney and liver diseases MESHD until 30 September 2020. ResultsMean follow-up time was 140 days for COVID-19 MESHD cases and 153 days for controls. 766 (95% confidence interval: 753 to 779) readmissions and 320 (312 to 328) deaths per 1,000 person-years were observed in COVID-19 MESHD cases, 3.5 (3.4 to 3.6) and 7.7 (7.2 to 8.3) times greater, respectively, than in controls. Rates of respiratory, diabetes MESHD and cardiovascular events were also significantly elevated in COVID-19 MESHD cases, at 770 (758 to 783), 127 (122 to 132) and 126 (121 to 131) events per 1,000 person-years, respectively. RRs were greater for individuals aged <70 than [≥] 70 years, and in ethnic minority groups than the White population, with the biggest differences observed for respiratory disease MESHD: 10.5 [9.7 to 11.4] for <70 years versus 4.6 [4.3 to 4.8] for [≥] 70 years, and 11.4 (9.8 to 13.3) for Non-White versus 5.2 (5.0 to 5.5) for White. ConclusionsIndividuals discharged from hospital following COVID-19 MESHD face elevated rates of multi-organ dysfunction compared with background levels, and the increase in risk is neither confined to the elderly nor uniform across ethnicities. The diagnosis, treatment and prevention of PCS require integrated rather than organ- or disease-specific approaches. Urgent research is required to establish risk factors for PCS.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes
SARS-CoV-2 Proteins

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.